Effects of grafting cell penetrate peptide and RGD on endocytosis and biological effects of Mg-CaPNPs-CKIP-1 siRNA carrier system in vitro

Abstract

Calcium phosphate nanoparticles (CaPNPs) have good biocompatibility as gene carriers; however, CaPNPs typically exhibit a low transfection efficiency. Cell penetrate peptide (TAT) can increase the uptake of nanoparticles but is limited by its non-specificity. Grafting adhesion peptide adhesion peptide on carriers can enhance their targeting. The Plekho1 gene encodes casein kinase-2 interacting protein-1 (CKIP-1) , which can negatively regulate osteogenic differentiation. Based on the above, we produced a Mg-CaPNPs-RGD-TAT-CKIP-1 siRNA carrier system via hydrothermal synthesis, silanization and adsorption. The effects of this carrier system on cell endocytosis and biological effects were evaluated by cell culture in vitro. The results demonstrate that CaPNPs with 7% Mg (60 nm particle size, short rod shape and good dispersion) were suitable for use as gene carriers. The carrier system boosted the endocytosis of MG63 cells and was helpful for promoting the differentiation of osteoblasts, and the dual-ligand system possessed a synergistic effect. The findings of this study show the tremendous potential of the Mg-CaPNPs-RGD-TAT-CKIP-1 siRNA carrier system for efficient delivery into cells and osteogenesis inducement.

Keywords

calcium phosphate nanoparticles / adhesion peptide / cell penetrate peptide / endocytosis / siRNA

References

[1] ZhouZ X, LiuX R, ZhuD C, WangY, ZhangZ, ZhouX F, QiuN S, ChenX S, ShenY Q. Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration [J]. Advanced Drug Delivery Reviews, 2017, 115: 115-154

[2] AkhtarS, BenterI. Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity [J]. Advanced Drug Delivery Reviews, 2007, 59(2): 164-182

[3] SzebeniJ, BaranyiL, SavayS, MilosevitsJ, BungerR, LavermanP, MetselaarJ M, StormG, Chanan-KhanA, LiebesL, MuggiaF M, CohenR, BarenholzY, AlvingC R. Role of complement activation in hypersensitivity reactions to Doxil and HYNIC PEG liposomes: Experimental and clinical studies [J]. Journal of Liposome Research, 2002, 12(12): 165-172

[4] van den HovenJ M, NemesR, MetselaarJ M, NuijenB, BeijnenJ H, StormG, SzebeniJ. Complement activation by PEGylated liposomes containing prednisolone [J]. European Journal of Pharmaceutical Sciences, 2013, 49(2): 265-271

[5] BakanF, KaraG, CokolC M, DenkbasE B. Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery [J]. Colloids and Surfaces B: Biointerfaces, 2017, 158: 175-181

[6] Rojas-SánchezL, ZhangE, SokolovaV, ZhongM, YanH, LuM, LiQ, YanH, EppleM. Genetic immunization against hepatitis B virus with calcium phosphate nanoparticles in vitro and in vivo [J]. Acta Biomaterialia, 2020, 110: 254-265

[7] KhanM A, WuV M, GhoshS, UskokovićV. Gene delivery using calcium phosphate nanoparticles: Optimization of the transfection process and the effects of citrate and poly (llysine) as additives [J]. Journal of Colloid and Interface Science, 2016, 471: 48-58

[8] SabourianP, YazdaniG, AshrafS S, FrounchiM, MashayekhanS, KianiS, KakkarA. Effect of physico-chemical properties of nanoparticles on their intracellular uptake [J]. International Journal of Molecular Sciences, 2020, 21(21): 8019

[9] LaskusA, KolmasJ. Ionic substitutions in non-apatitic calcium phosphates [J]. International Journal of Molecular Sciences, 2017, 18122542

[10] TiteT, PopaA C, BalescuL M, BogdanI M, PasukI, FerreiraJ M F, StanG E. Cationic substitutions in hydroxyapatite: Current status of the derived biofunctional effects and their in vitro interrogation methods [J]. Materials (Basel, Switzerland) , 2018, 11112081

[11] HanifiA, FathiM H, SadeghiH, VarshosazJ M. Mg²⁺ substituted calcium phosphate nano particles synthesis for non viral gene delivery application [J]. Journal of Materials Science: Materials in Medicine, 2010, 2182393-2401

[12] KimW, KimW K, LeeK, SonM J, KwakM, ChangW S, MinJ K, SongN W, LeeJ, BaeK H. A reliable approach for assessing size-dependent effects of silica nanoparticles on cellular internalization behavior and cytotoxic mechanisms [J]. International Journal of Nanomedicine, 2019, 14: 7375-7387

[13] NeumannS, KovtunA, DietzelI D, EppleM, HeumannR. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection [J]. Biomaterials, 2009, 30(35): 6794-6802

[14] ChenL-j, ChenT, CaoJ. Effect of Tb/Mg doping on composition and physical properties of hydroxyapatite nanoparticles for gene vector application [J]. Transactions of Nonferrous Metals Society of China, 2018, 28(1): 125-136

[15] ZouL, PengQ L, WangP, ZhouB T. Progress in research and application of HIV-1 TAT-derived cell-penetrating peptide [J]. The Journal of Membrane Biology, 2017, 250(2): 115-122

[16] ZhangW J, MaoZ W, GaoC Y. Preparation of TAT peptide-modified poly (N-isopropylacrylamide) microgel particles and their cellular uptake, intracellular distribution, and influence on cytoviability in response to temperature change [J]. Journal of Colloid and Interface Science, 2014, 434: 122-129

[17] YamanoS, DaiJ, YuviencoC, KhapliS, MoursiA M, MontclareJ K. Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis [J]. Journal of Controlled Release, 2011, 152(2): 278-285

[18] LiQ, HaoX F, WangH N, GuoJ T, RenX K, XiaS H, ZhangW C, FengY K. Multifunctional REDV-G-TAT-G-NLS-Cys peptide sequence conjugated gene carriers to enhance gene transfection efficiency in endothelial cells [J]. Colloids and Surfaces B: Biointerfaces, 2019, 184: 110510

[19] HoA, SchwarzeS R, MermelsteinS J, WaksmanG, DowdyS F. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo [J]. Cancer Research, 2001, 61(2): 474-477

[20] MarcucciF, LefoulonF. Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress [J]. Drug Discovery Today, 2004, 9(5): 219-228

[21] LvH, ZhuQ, LiuK W, ZhuM M, ZhaoW F, MaoY, LiuK H. Coupling of a bifunctional peptide R13 to OTMCSPEI copolymer as a gene vector increases transfection efficiency and tumor targeting [J]. International Journal of Nanomedicine, 2014, 91311-1322

[22] ChenT, ChenL-j, HeH-li. Influence of HAnps carrier system with doping Mg and grafting RGD on endocytosis of MG63 cells [J]. Journal of Central South University (Science and Technology) , 2017, 48(3): 625-634 (in Chinese)

[23] WuD N, ZhangY N, XuX T, GuoT, XieD M, ZhuR, ChenS F, RamakrishnaS, HeL M. RGD/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration [J]. Acta Biomaterialia, 2018, 72: 266-277

[24] HuangZ G, LvF M, WangJ, CaoS J, LiuZ P, LiuY, LuW Y. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability [J]. International Journal of Pharmaceutics, 2019, 556: 217-225

[25] LuK F, YinX S, WengT J, XiS L, LiL, XingG C, ChengX, YangX, ZhangL Q, HeF C. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1 [J]. Nature Cell Biology, 2008, 10(8): 994-1002

[26] SafiA, VandrommeM, CaussanelS, ValdacciL, BaasD, VidalM, BrunG, SchaefferL, GoillotE. Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation [J]. Molecular and Cellular Biology, 2004, 24(3): 1245-1255

[27] GuoB S, ZhangB T, ZhengL Z, TangT, LiuJ, WuH, YangZ J, PengS L, HeX J, ZhangH Q, YueK K, HeF C, ZhangL Q, QinL, BianZ X, TanW H, LiangZ C, LuA P, ZhangG. Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation [J]. Bone, 2014, 59: 76-88

[28] SuzukiT, IshigakiK, MiyakeM. Synthetic hydroxyapatites employed as inorganic cation-exchangers [J]. Journal of the Chemical Society, Faraday Transactions 1: Physical Chemistry in Condensed Phases, 1981, 5(5): 1059-1062

[29] RenF, LengY, XinR, GeX. Synthesis, characterization and ab initio simulation of magnesium-substituted hydroxyapatite [J]. Acta Biomaterialia, 2010, 6(7): 2787-2796

[30] LaurencinD, Almora-BarriosN, deL N H, GervaisC, BonhommeC, MauriF, ChrzanowskiW, KnowlesJ C, NewportR J, WongA, GanZ, SmithM E. Magnesium incorporation into hydroxyapatite [J]. Biomaterials, 2011, 32(7): 1826-1837

[31] WangH-y, CuiY-n, ZhangC-Y. Influence factors on the zeta potential of colloid particle [J]. China Medical Herald, 2010, 7(20): 28-30 (in Chinese)

[32] RetamalM R R, BabickF, HillemannL. Zeta potential measurements for non-spherical colloidal particles — Practical issues of characterisation of interfacial properties of nanoparticles [J]. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2017, 532: 516-521

[33] ZhangS, LiJ, LykotrafitisG, BaoG, SureshS. Size-dependent endocytosis of nanoparticles [J]. Advanced Materials, 2009, 21(4): 419-424

[34] ChuaP H, NeohK G, KangE T, WangW. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion [J]. Biomaterials, 2008, 29(10): 1412-1421

[35] TaubenbergerA V, WoodruffM A, BaiH, MullerD J, HutmacherD W. The effect of unlocking RGD-motifs in collagen I on pre-osteoblast adhesion and differentiation [J]. Biomaterials, 2010, 31(10): 2827-2835

[36] BellisS L. Advantages of RGD peptides for directing cell association with biomaterials [J]. Biomaterials, 2011, 32(18): 4205-4210

[37] WilkinsonA L, BarrettJ W, SlackR J. Pharmacological characterisation of a tool αvβ₁ integrin small molecule RGD-mimetic inhibitor [J]. European Journal of Pharmacology, 2019, 842: 239-247

[38] HuangJ-c, CaiH-r, JiangY-quan. Construction of RGD-TAT modified liposomes and evaluation of its targeting on glioma [J]. Chinese Journal of Biochemical Pharmaceutics, 2014, 34(3): 1-3 (in Chinese)

[39] alS M, HeL, PeynshaertK, CousaertJ, VercauterenD, BraeckmansK, deS S C, JonesA T. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat [J]. Journal of Controlled Release, 2012, 161(1): 132-141

[40] FusaroM, CrepaldiG, MaggiS, D’AngeloA, CaloL, MiozzoD, FornasieriA, GallieniM. Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: Hope for lower risks with alternative therapies.[J]. Current Vascular Pharmacology, 2011, 9(6): 763-769

[41] MarelliB, GhezziC E, BarraletJ E, BoccacciniA R, NazhatS N. Three-dimensional mineralization of dense nanofibrillar collagen-bioglass hybrid scaffolds [J]. Biomacromolecules, 2010, 11(6): 1470-1479

[42] FuC-g, LiuJ, XiaH-bin. Biological characteristics of osteopontin and its role in bone remodeling [J]. Journal of Clinical Stomatology, 2012, 28(8): 506-508 (in Chinese)